VANI Vivani Medical, Inc.
Healthcare$1.20+3.45%ClosedMarket Cap: $70.9M
As of 2026-05-25
Valuation
View DetailsP/E (TTM)
—
PEG
—
P/B
5.11
P/S
0.00
EV/EBITDA
-2.54
DCF Value
$-0.05
FCF Yield
-37.4%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-264.0%
ROA
-64.0%
ROIC
-74.4%
Financials
View All| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 null | $0.00 | $-6.8M | $— |
| Q4 null | $0.00 | $-6.6M | $— |
| FY null | $0.00 | $-26.6M | $— |
| Q3 null | $0.00 | $-6.5M | $— |
Analyst Ratings
View AllConsensus
Buy
Target (Consensus)
$—
Target (Median)
$—
Target Range
$— - $—
1 Strong Buy2 Buy0 Hold0 Sell0 Strong Sell
HC Wainwright & Co.Buy
2026-03-31HC Wainwright & Co.Buy
2025-09-02Trading Activity
Insider Trades
View AllWilliams Greggdirector, 10 percent owner:
BuyTue May 19
Williams Greggdirector, 10 percent owner:
BuyThu Apr 16
Williams Greggdirector, 10 percent owner:
BuyMon Mar 16
Williams Greggdirector, 10 percent owner:
BuyMon Mar 16
Williams Greggdirector, 10 percent owner:
BuyTue Feb 17
Company Info
Sector
Healthcare
Industry
Medical - Devices
Country
US
Exchange
—
Beta
2.35
Vivani Medical, Inc., a clinical stage company, develops various implants that treat chronic diseases with high unmet medical need. It engages in developing a portfolio of miniature drug implants to deliver minimally fluctuating drug profiles; and implantable visual prostheses devices to deliver useful artificial vision to blind individuals. The company is headquartered in Emeryville, California.